These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 36679846)
1. Evaluation of Whole-Cell and Acellular Pertussis Vaccines in the Context of Long-Term Herd Immunity. Szwejser-Zawislak E; Wilk MM; Piszczek P; Krawczyk J; Wilczyńska D; Hozbor D Vaccines (Basel); 2022 Dec; 11(1):. PubMed ID: 36679846 [TBL] [Abstract][Full Text] [Related]
2. Diphtheria-tetanus-acellular pertussis vaccine adsorbed (Triacelluvax; DTaP3-CB): a review of its use in the prevention of Bordetella pertussis infection. Matheson AJ; Goa KL Paediatr Drugs; 2000; 2(2):139-59. PubMed ID: 10937466 [TBL] [Abstract][Full Text] [Related]
3. Whole-Cell or Acellular Pertussis Primary Immunizations in Infancy Determines Adolescent Cellular Immune Profiles. van der Lee S; Hendrikx LH; Sanders EAM; Berbers GAM; Buisman AM Front Immunol; 2018; 9():51. PubMed ID: 29416544 [TBL] [Abstract][Full Text] [Related]
4. Quantity and Quality of Antibodies After Acellular Versus Whole-cell Pertussis Vaccines in Infants Born to Mothers Who Received Tetanus, Diphtheria, and Acellular Pertussis Vaccine During Pregnancy: A Randomized Trial. Wanlapakorn N; Maertens K; Vongpunsawad S; Puenpa J; Tran TMP; Hens N; Van Damme P; Thiriard A; Raze D; Locht C; Poovorawan Y; Leuridan E Clin Infect Dis; 2020 Jun; 71(1):72-80. PubMed ID: 31418814 [TBL] [Abstract][Full Text] [Related]
5. A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children. Pichichero ME; Deloria MA; Rennels MB; Anderson EL; Edwards KM; Decker MD; Englund JA; Steinhoff MC; Deforest A; Meade BD Pediatrics; 1997 Nov; 100(5):772-88. PubMed ID: 9346976 [TBL] [Abstract][Full Text] [Related]
6. Recommendations to control pertussis prioritized relative to economies: A Global Pertussis Initiative update. Forsyth KD; Tan T; von König CW; Heininger U; Chitkara AJ; Plotkin S Vaccine; 2018 Nov; 36(48):7270-7275. PubMed ID: 30337176 [TBL] [Abstract][Full Text] [Related]
7. Whole-cell or acellular pertussis vaccination in infancy determines IgG subclass profiles to DTaP booster vaccination. van der Lee S; Sanders EAM; Berbers GAM; Buisman AM Vaccine; 2018 Jan; 36(2):220-226. PubMed ID: 29199041 [TBL] [Abstract][Full Text] [Related]
8. New Pertussis Vaccines: A Need and a Challenge. Hozbor D Adv Exp Med Biol; 2019; 1183():115-126. PubMed ID: 31432399 [TBL] [Abstract][Full Text] [Related]
9. Human Immune Responses to Pertussis Vaccines. Ausiello CM; Mascart F; Corbière V; Fedele G Adv Exp Med Biol; 2019; 1183():99-113. PubMed ID: 31342460 [TBL] [Abstract][Full Text] [Related]
10. Cell-mediated and antibody responses to Bordetella pertussis antigens in children vaccinated with acellular or whole-cell pertussis vaccines. The Progetto Pertosse-CMI Working Group. Cassone A; Ausiello CM; Urbani F; Lande R; Giuliano M; La Sala A; Piscitelli A; Salmaso S Arch Pediatr Adolesc Med; 1997 Mar; 151(3):283-9. PubMed ID: 9080938 [TBL] [Abstract][Full Text] [Related]
11. Randomized study of immune responses to two Tdap vaccines among adolescents primed with DTaP and comparison with results among adolescents primed with DTwP. Decker MD; Greenberg DP; Johnson DR; Pool V Vaccine; 2019 Aug; 37(35):5003-5008. PubMed ID: 31301919 [TBL] [Abstract][Full Text] [Related]
12. A cellular pertussis vaccine (Infanrix-DTPa; SB-3). A review of its immunogenicity, protective efficacy and tolerability in the prevention of Bordetella pertussis infection. Patel SS; Wagstaff AJ Drugs; 1996 Aug; 52(2):254-75. PubMed ID: 8841742 [TBL] [Abstract][Full Text] [Related]
13. Epidemiology of pertussis and Haemophilus influenzae type b disease in Canada with exclusive use of a diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b pediatric combination vaccine and an adolescent-adult tetanus-diphtheria-acellular pertussis vaccine: implications for disease prevention in the United States. Greenberg DP; Doemland M; Bettinger JA; Scheifele DW; Halperin SA; ; Waters V; Kandola K Pediatr Infect Dis J; 2009 Jun; 28(6):521-8. PubMed ID: 19436236 [TBL] [Abstract][Full Text] [Related]
14. Assessment of safety and efficacy against Bordetella pertussis of a new tetanus-reduced dose diphtheria-acellular pertussis vaccine in a murine model. Kwon HJ; Han SB; Kim BR; Kang KR; Huh DH; Choi GS; Ahn DH; Kang JH BMC Infect Dis; 2017 Apr; 17(1):247. PubMed ID: 28376777 [TBL] [Abstract][Full Text] [Related]
15. Impact of maternal diphtheria-tetanus-acellular pertussis vaccination on pertussis booster immune responses in toddlers: Follow-up of a randomized trial. Martinón-Torres F; Halperin SA; Nolan T; Tapiéro B; Perrett KP; de la Cueva IS; García-Sicilia J; Stranak Z; Vanderkooi OG; Kosina P; Rumlarova S; Virta M; Arribas JMM; Miranda-Valdivieso M; Novas BA; Bozensky J; Ortega MJC; Amador JTR; Baca M; Palomino EE; Zuccotti GV; Janota J; Marchisio PG; Kostanyan L; Meyer N; Ceregido MA; Cheuvart B; Kuriyakose SO; Mesaros N Vaccine; 2021 Mar; 39(11):1598-1608. PubMed ID: 33612341 [TBL] [Abstract][Full Text] [Related]
16. Changing from whole-cell to acellular pertussis vaccines would trade superior tolerability for inferior protection. Herzog C Expert Rev Vaccines; 2015; 14(8):1065-72. PubMed ID: 26098640 [TBL] [Abstract][Full Text] [Related]
17. Mucosal Immunization with DTaP Confers Protection against Hall JM; Bitzer GJ; DeJong MA; Kang J; Wong TY; Wolf MA; Bevere JR; Barbier M; Damron FH Infect Immun; 2021 Nov; 89(12):e0034621. PubMed ID: 34516235 [TBL] [Abstract][Full Text] [Related]